Navigation Links
Francesco Granata, M.D. Joins Board of Prismic Pharmaceuticals
Date:12/3/2013

SCOTTSDALE, Ariz., Dec. 3, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based, commercial-stage pharmaceutical company focused on prescription Medical Foods, today announced the election of Francesco Granata, M.D., to its Board of Directors.

Dr. Granata is currently Executive in Residence at Warburg Pincus, a leading private equity firm focused on growth investing.  He is an accomplished healthcare executive with more than 35 years of experience in the international pharmaceutical and biotechnology industries.  Before joining Warburg Pincus, Dr. Granata held senior management positions at Pfizer, where he was President of the Northern Europe region; Schering-Plough, where he served as Group Vice President and President for the Europe and Canada region; and most recently at Biogen Idec Inc., where he was Executive Vice President of Global Commercial Operations, with responsibility for worldwide Commercial Operations and Medical Affairs.  Dr. Granata is also a Board Member of Circassia, a UK-based specialty Biopharmaceutical company and Italfarmaco, one of Italy's leading international pharmaceutical groups. 

"Francesco Granata has had an exceptionally successful career and brings a wealth of healthcare experience and strategic vision to our Board of Directors," commented Peter Moriarty, Chairman and CEO of Prismic.  "Prior to joining the pharmaceutical industry, Francesco practiced as a physician and surgeon, specializing in Cardiology.  He has also been Chairman of the European Committee of the Pharmaceutical Research and Manufacturers Association of America and Co-Chairman of the Heads of Europe Committee of the European Federation of Pharmaceutical Industries and Associations.  We are honored that he has accepted the invitation to join our Board.  We are confident of the contribution he will make in helping the Board to guide Prismic's continuing path to commercial success and increased value for our shareholders."  

"Prismic has an extremely interesting and innovative portfolio of patent-protected products," stated Dr. Granata. "I believe that the company has identified products and market opportunities that are medically important as well as commercially very attractive. Prismic has the choice of exploiting those opportunities alone or in partnership with other commercial entities in the United States and Internationally.  I look forward to working with my fellow Board members to help Management drive optimum value for our shareholders."

About Prismic Pharmaceuticals, Inc.
Prismic Pharmaceuticals, Inc., is a privately held, commercial-stage pharmaceutical company focused on the development and marketing of prescription Medical Foods for the clinical dietary management of the metabolic processes associated with many of the disorders associated with the aging population, particularly where inflammation is involved.  The company, founded in 2011, is headquartered in Scottsdale, Arizona, with offices in Boston, USA, and London, England. Contact 480.422.1810 or visit www.PrismicPharma.com.

INFORMATION CONTACT
Peter Moriarty
Tel: 480.422.1810


'/>"/>
SOURCE Prismic Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Watson Names Lisa DeFrancesco Vice President, Global Investor Relations
2. Guri Stark Joins CorTechs Labs as CEO
3. Eisai Joins Groundbreaking Tuberculosis Drug Accelerator Partnership to Discover New Tuberculosis Drugs
4. BD Joins National Patient Safety Foundation Corporate Council, Furthers Commitment to Safety
5. Rafarma Pharmaceuticals, Inc. (RAFA) Joins in Economic Development Coalition to Increase Biotech Growth in Terbuny, Russia.
6. Helping New Yorkers Prevent Heart Attacks: Itamar Medical Joins The Fight With New Campaign
7. Bay Alarm Medical Joins The Fight To End Hunger
8. Chris Newmarker joins MPMN and Qmed
9. State Senator Mae Beavers Joins Local Leaders, Retailers, Pharmacists To Launch Anti-Smurfing Public Awareness Campaign
10. Jefferson School of Population Health joins the Alliance for Rational Use of NSAIDs
11. RidgeCrest Herbals New Thyroid Thrive Joins Companys List Of Top 10 Bestsellers In Record Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... 28, 2017  Orexigen Therapeutics, Inc. (Nasdaq: ... the fourth quarter and year ended December 31, 2016. ... transformational progress for Orexigen, beginning with the re-acquisition of ... early March, the team at Orexigen demonstrated remarkable focus, ... reshaped and strengthened our Company while rewarding us full ...
(Date:3/28/2017)... 2017 The global market for ... the top three companies, namely Shimadzu Corporation, Thermo Fisher ... 49% of the overall market in 2015, observes Transparency ... is intensely competitive and has few players, most of ... factors have restricted the entry of new players in ...
(Date:3/28/2017)... TEL AVIV, Israel , March 28, 2017 /PRNewswire/ ... Israel . This new business entity, Emosis Ltd, headquartered ... to research and development of novel assays complementing the mother company ... relevant, locally support commercialization and sales development of Emosis kits. ... This strategic move starts ...
Breaking Medicine Technology:
(Date:3/28/2017)... (PRWEB) , ... March 28, ... ... a non-profit medical society dedicated to advancing the science and clinical practice ... from its RSSearch Patient Registry, a multi-institutional, observational registry established to standardize ...
(Date:3/28/2017)... ... ... Alert Sentry Group LLC., a leader in the Personal Emergency Response System industry, introduced ... Plus. These iSAFE products are the most affordable and most advanced medical alert systems ... direct GPS Location and two-way calling with the push of a button on a ...
(Date:3/28/2017)... ... March 28, 2017 , ... WHO: , Dr. Paul Thomas; Dr. ... , Medical doctors and PhD scientists will speak to the press on behalf of ... support of an independent vaccine safety commission. , WHERE: , Zenger Room, National ...
(Date:3/28/2017)... , ... March 28, 2017 , ... The Radiology ... FRBMA, has begun to serve as its new executive director. Mr. Still was selected ... Search Committee. , “Bob, as he is known to our members, has been ...
(Date:3/28/2017)... ... March 28, 2017 , ... Award-winning medical ... begin serving as new board chair for Orange County health care system CalOptima ... remainder of soon-to-be former chair Mark Refowitz’s term, which runs through June 30 ...
Breaking Medicine News(10 mins):